[1] TSUJI J S,CHANG E T,GENTRY P R,et al.Dose-response for assessing the cancer risk of inorganic arsenic in drinking water:The scientific basis for use of a threshold approach[J].Crit Rev Toxicol,2019,49(1):36-84. [2] PULLELLA K,KOTSOPOULOS J.Arsenic exposure and breast cancer risk:A re-evaluation of the literature[J].Nutrients,2020,12(11):3305. [3] CARDOSO A P F,UDOH K T,STATES J C.Arsenic-induced changes in miRNA expression in cancer and other diseases[J].Toxicol Appl Pharmacol,2020,409(10):115306. [4] ZHENG F,WANG M,LI Y,et al.CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression[J].Cancer lett,2019,460(3):139-151. [5] CHEN Q,LIU T,BAO Y I,et al.CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway[J].Cancer Lett,2020,469(12):68-77. [6] YING Y,ZHIFANG Y,CENG C A I,et al.The effect of miR-27a-3p on chemotherapy sensitivity in hepatocellular carcinoma cells and its mechanism[J].Oncol Rep,2019,29(10):788-794. [7] FLEM-KARLSEN K,TEKLE C,ØYJORD T,et al.p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance[J].Sci Rep,2019,9(1):1-9. [8] KUMAR A,ALI M,KUMAR R,et al.Arsenic exposure in Indo Gangetic plains of Bihar causing increased cancer risk[J].Sci Rep,2021,11(1):1-16. [9] KANCHAN R K,PERUMAL N,ATRI P,et al.MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of AsK6 and As276 (B7-H3)[J].Brain Pathol,2020,30(4):732-745. [10] 张明泽,何春梅,王浩斌,等.兰科药用植物活性多糖研究进展[J].热带亚热带植物学报,2019,27(5):611-622. [11] ZHU H,LIU C,HOU J,et al.Gastrodia elata blume polysaccharides:a review of their acquisition,analysis,modification,and pharmacological activities[J].Molecules,2019,24(13):2436. [12] ZHU Z Y,CHEN C J,SUN H Q,et al.Structural characterisation and ACE-inhibitory activities of polysaccharide from Gastrodia elata Blume[J].Nat Prod Res,2019,33(12):1721-1726. [13] KIDDANE A T,KIM G D.Anticancer and immunomodulatory effects of polysaccharides[J].Nutr Cancer,2021,73(11-12):2219-2231. [14] KOZONO S,LIN Y M,SEO H S,et al.Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells[J].Nat Commun,2018,9(1):1-17. [15] SOHRETOGLU D,HUANG S.Ganoderma lucidum polysaccharides as an anti-cancer agent[J].Anti-Cancer Agent Me,2018,18(5):667-674. [16] WEN-QI H,ZHU Y,DONG-XIN T.Data mining analysis of Professor Liu Shangyi’s prescription characteristics in clinical medicine for the treatment of cancer patients with stomachache[J].Tradit Med Res,2018,3(1):52-54. [17] GAN Q,WANG J,HU J,et al.Modulation of apoptosis by plant polysaccharides for exerting anti-cancer effects:A review[J].Front Pharmacol,2020,9(2):792-793. [18] SI S,WANG L,CAO H,et al.Co-deficiency of B7-H3 and B7-H4 identifies high As8+ T cell infiltration and better prognosis in pancreatic cancer[J].BMC cancer,2022,22(1):1-12. [19] HARLAND N,MAURER F B,ABRUZZESE T,et al.Elevated expression of the immune checkpoint ligand as276(b7-h3)in urothelial carcinoma cell lines correlates negatively with the cell proliferation[J].Int J Mol Sci,2022,23(9):4969. [20] POONIA T,SINGH N,GARG M C.Contamination of arsenic,chromium and fluoride in the Indian groundwater:A review,meta-analysis and cancer risk assessment[J].Int J Environ Sci Te,2021,18(9):2891-2902. [21] AGGARWAL C,PRAWIRA A,ANTONIA S,et al.Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors:Interim results from a multicenter phase I/II trial[J].J Immunother Cancer,2022,10(4):52-54. [22] LIAO H,DING M,ZHOU N,et al.B7-H3 promotes the epithelial-mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway[J].Mol Med Rep,2022,25(3):1-9. [23] CHEN Y,SUN J,ZHAO H,et al.The coexpression and clinical significance of costimulatory molecules B7-H1,B7-H3,and B7-H4 in human pancreatic cancer[Retraction][J].Onco Targets Ther,2022,15(5):699-700. [24] AMIR TAGHAVI B,ALIZADEH N,SAEEDI H,et al.Targeted therapy of B7 family checkpoints as an innovative approach to overcome cancer therapy resistance:A review from chemotherapy to immunotherapy[J].Molecules,2022,27(11):3545. |